메뉴 건너뛰기




Volumn 83, Issue 2, 2012, Pages 293-302

Anaplastic large cell lymphoma, ALK-positive

Author keywords

ALK; ALK inhibitors; Allogeneic transplant; Anaplastic lymphoma; Autologous transplant; CD30

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ASPARAGINASE; BLEOMYCIN; BRENTUXIMAB VEDOTIN; CARMUSTINE; CD30 ANTIGEN; CRIZOTINIB; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; NUCLEOPHOSMIN; PREDNISONE; T LYMPHOCYTE RECEPTOR; TIOGUANINE; VINCRISTINE;

EID: 84864039901     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2012.02.005     Document Type: Review
Times cited : (100)

References (78)
  • 1
    • 0021972684 scopus 로고
    • The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
    • October
    • Stein H., Mason D.Y., Gerdes J., et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66(October (4)):848-858.
    • (1985) Blood , vol.66 , Issue.4 , pp. 848-858
    • Stein, H.1    Mason, D.Y.2    Gerdes, J.3
  • 3
    • 0022105502 scopus 로고
    • Lymphoid malignancies in Nebraska: a hypothesis
    • August
    • Weisenburger D.D. Lymphoid malignancies in Nebraska: a hypothesis. Nebr Med J 1985, 70(August (8)):300-305.
    • (1985) Nebr Med J , vol.70 , Issue.8 , pp. 300-305
    • Weisenburger, D.D.1
  • 4
    • 0026709610 scopus 로고
    • Non-Hodgkin's lymphoma and occupational exposure
    • October
    • Scherr P.A., Hutchison G.B., Neiman R.S. Non-Hodgkin's lymphoma and occupational exposure. Cancer Res 1992, 52(October (19 Suppl.)):5503s-5509s.
    • (1992) Cancer Res , vol.52 , Issue.19 SUPPL.
    • Scherr, P.A.1    Hutchison, G.B.2    Neiman, R.S.3
  • 5
    • 0024991280 scopus 로고
    • Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska
    • Weisenburger D.D. Environmental epidemiology of non-Hodgkin's lymphoma in eastern Nebraska. Am J Ind Med 1990, 18(3):303-305.
    • (1990) Am J Ind Med , vol.18 , Issue.3 , pp. 303-305
    • Weisenburger, D.D.1
  • 6
    • 0024989347 scopus 로고
    • A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska
    • September
    • Zahm S.H., Weisenburger D.D., Babbitt P.A., Saal R.C. A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska. Epidemiology 1990, 1(September (5)):349-356.
    • (1990) Epidemiology , vol.1 , Issue.5 , pp. 349-356
    • Zahm, S.H.1    Weisenburger, D.D.2    Babbitt, P.A.3    Saal, R.C.4
  • 9
    • 0037481757 scopus 로고    scopus 로고
    • Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient
    • Mira J.A., Fernández-Alonso J., Macías J., et al. Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient. J Infect 2003.
    • (2003) J Infect
    • Mira, J.A.1    Fernández-Alonso, J.2    Macías, J.3
  • 10
    • 0032908093 scopus 로고    scopus 로고
    • Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases
    • May
    • Arber D.A., Chang K.L., Weiss L.M. Peripheral T-cell lymphoma with Toutonlike tumor giant cells associated with HIV infection: report of two cases. Am J Surg Pathol 1999, 23(May (5)):519-522.
    • (1999) Am J Surg Pathol , vol.23 , Issue.5 , pp. 519-522
    • Arber, D.A.1    Chang, K.L.2    Weiss, L.M.3
  • 11
    • 0034594369 scopus 로고    scopus 로고
    • Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIV-positive man
    • January-February
    • Burke A.P., Andriko J.A., Virmani R. Anaplastic large cell lymphoma (CD 30+), T-phenotype, in the heart of an HIV-positive man. Cardiovasc Pathol 2000, 9(January-February (1)):49-52.
    • (2000) Cardiovasc Pathol , vol.9 , Issue.1 , pp. 49-52
    • Burke, A.P.1    Andriko, J.A.2    Virmani, R.3
  • 12
    • 66349108519 scopus 로고    scopus 로고
    • HIV-associated anaplastic large cell lymphoma: a report of three cases
    • September
    • Nava V.E., Cohen P., Kalan M., Ozdemirli M. HIV-associated anaplastic large cell lymphoma: a report of three cases. AIDS 2008, 22(September (14)):1892-1894.
    • (2008) AIDS , vol.22 , Issue.14 , pp. 1892-1894
    • Nava, V.E.1    Cohen, P.2    Kalan, M.3    Ozdemirli, M.4
  • 13
    • 0034554843 scopus 로고    scopus 로고
    • CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
    • [Review], December
    • Stein H., Foss H.D., Dürkop H., et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000, 96(December (12)):3681-3695. [Review].
    • (2000) Blood , vol.96 , Issue.12 , pp. 3681-3695
    • Stein, H.1    Foss, H.D.2    Dürkop, H.3
  • 14
    • 34249665451 scopus 로고    scopus 로고
    • Anaplastic large cell lymphoma
    • [Review], May
    • Medeiros L.J., Elenitoba-Johnson K.S. Anaplastic large cell lymphoma. Am J Clin Pathol 2007, 127(May (5)):707-722. [Review].
    • (2007) Am J Clin Pathol , vol.127 , Issue.5 , pp. 707-722
    • Medeiros, L.J.1    Elenitoba-Johnson, K.S.2
  • 15
    • 34547638047 scopus 로고    scopus 로고
    • Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    • [Epub 2007 Jul 11], August
    • Soda M., Choi Y.L. Enomoto Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448(August (7153)):561-566. [Epub 2007 Jul 11].
    • (2007) Nature , vol.448 , Issue.7153 , pp. 561-566
    • Soda, M.1    Choi, Y.L.2
  • 16
    • 61349164241 scopus 로고    scopus 로고
    • Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK
    • February
    • Grzelinski M., Steinberg F., Martens T., et al. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia 2009, 11(February (2)):145-156.
    • (2009) Neoplasia , vol.11 , Issue.2 , pp. 145-156
    • Grzelinski, M.1    Steinberg, F.2    Martens, T.3
  • 17
    • 0031035052 scopus 로고    scopus 로고
    • Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system
    • January
    • Iwahara T., Fujimoto J., Wen D. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 1997, 14(January (4)):439-449.
    • (1997) Oncogene , vol.14 , Issue.4 , pp. 439-449
    • Iwahara, T.1    Fujimoto, J.2    Wen, D.3
  • 18
    • 54049149961 scopus 로고    scopus 로고
    • Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
    • October
    • Janoueix-Lerosey I., Lequin D., Brugières L. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008, 455(October (7215)):967-970.
    • (2008) Nature , vol.455 , Issue.7215 , pp. 967-970
    • Janoueix-Lerosey, I.1    Lequin, D.2    Brugières, L.3
  • 19
    • 54049120220 scopus 로고    scopus 로고
    • Activating mutations in ALK provide a therapeutic target in neuroblastoma
    • October
    • George R.E., Sanda T., Hanna M., et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 2008, 455(October (7215)):975-978.
    • (2008) Nature , vol.455 , Issue.7215 , pp. 975-978
    • George, R.E.1    Sanda, T.2    Hanna, M.3
  • 20
    • 65549154968 scopus 로고    scopus 로고
    • Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma
    • March
    • Singh R.R., Cho-Vega J.H., Davuluri Y., et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009, 69(March (6)):2550-2558.
    • (2009) Cancer Res , vol.69 , Issue.6 , pp. 2550-2558
    • Singh, R.R.1    Cho-Vega, J.H.2    Davuluri, Y.3
  • 21
    • 0032521239 scopus 로고    scopus 로고
    • ALK-positive lymphoma: a single disease with a broad spectrum of morphology
    • March
    • Benharroch D., Meguerian-Bedoyan Z., Lamant L., et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998, 91(March (6)):2076-2084.
    • (1998) Blood , vol.91 , Issue.6 , pp. 2076-2084
    • Benharroch, D.1    Meguerian-Bedoyan, Z.2    Lamant, L.3
  • 22
    • 0031689795 scopus 로고    scopus 로고
    • ALK expression defines a distinct group of T/null lymphomas (" ALK lymphomas" ) with a wide morphological spectrum
    • September
    • Falini B., Bigerna B., Fizzotti M., et al. ALK expression defines a distinct group of T/null lymphomas (" ALK lymphomas" ) with a wide morphological spectrum. Am J Pathol 1998, 153(September (3)):875-886.
    • (1998) Am J Pathol , vol.153 , Issue.3 , pp. 875-886
    • Falini, B.1    Bigerna, B.2    Fizzotti, M.3
  • 23
    • 0030970804 scopus 로고    scopus 로고
    • Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type
    • April
    • Pileri S.A., Pulford K., Mori S. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type. Am J Pathol 1997, 150(April (4)):1207-1211.
    • (1997) Am J Pathol , vol.150 , Issue.4 , pp. 1207-1211
    • Pileri, S.A.1    Pulford, K.2    Mori, S.3
  • 24
    • 33645228963 scopus 로고    scopus 로고
    • ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases
    • February
    • Vassallo J., Lamant L., Brugieres L. ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases. Am J Surg Pathol 2006, 30(February (2)):223-229.
    • (2006) Am J Surg Pathol , vol.30 , Issue.2 , pp. 223-229
    • Vassallo, J.1    Lamant, L.2    Brugieres, L.3
  • 25
    • 33748861223 scopus 로고    scopus 로고
    • From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation
    • September
    • Soumelis V., Liu Y.J. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur J Immunol 2006, 36(September (9)):2286-2292.
    • (2006) Eur J Immunol , vol.36 , Issue.9 , pp. 2286-2292
    • Soumelis, V.1    Liu, Y.J.2
  • 26
    • 0034554843 scopus 로고    scopus 로고
    • CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features
    • December
    • Stein H., Foss H.D., Dürkop H. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000, 96(December (12)):3681-3695.
    • (2000) Blood , vol.96 , Issue.12 , pp. 3681-3695
    • Stein, H.1    Foss, H.D.2    Dürkop, H.3
  • 27
    • 0029803574 scopus 로고    scopus 로고
    • Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules
    • November
    • Foss H.D., Anagnostopoulos I., Araujo I. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996, 88(November (10)):4005-4011.
    • (1996) Blood , vol.88 , Issue.10 , pp. 4005-4011
    • Foss, H.D.1    Anagnostopoulos, I.2    Araujo, I.3
  • 28
    • 0030944428 scopus 로고    scopus 로고
    • Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin
    • February
    • Krenacs L., Wellmann A., Sorbara L. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997, 89(February (3)):980-989.
    • (1997) Blood , vol.89 , Issue.3 , pp. 980-989
    • Krenacs, L.1    Wellmann, A.2    Sorbara, L.3
  • 29
    • 0030034745 scopus 로고    scopus 로고
    • High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining
    • January
    • Lamant L., Meggetto F., al Saati T., et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996, 87(January (1)):284-291.
    • (1996) Blood , vol.87 , Issue.1 , pp. 284-291
    • Lamant, L.1    Meggetto, F.2    al Saati, T.3
  • 30
    • 0025139773 scopus 로고
    • CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35
    • February
    • Mason D.Y., Bastard C., Rimokh R., et al. CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990, 74(February (2)):161-168.
    • (1990) Br J Haematol , vol.74 , Issue.2 , pp. 161-168
    • Mason, D.Y.1    Bastard, C.2    Rimokh, R.3
  • 31
    • 0028198206 scopus 로고
    • Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
    • Erratum in: Science 1995;267(January (5196)):316-317, March
    • Morris S.W., Kirstein M.N., Valentine M.B., et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263(March (5151)):1281-1284. Erratum in: Science 1995;267(January (5196)):316-317.
    • (1994) Science , vol.263 , Issue.5151 , pp. 1281-1284
    • Morris, S.W.1    Kirstein, M.N.2    Valentine, M.B.3
  • 32
    • 0027194670 scopus 로고
    • High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children
    • August
    • Brousset P., Rochaix P., Chittal S., et al. High incidence of Epstein-Barr virus detection in Hodgkin's disease and absence of detection in anaplastic large-cell lymphoma in children. Histopathology 1993, 23(August (2)):189-191.
    • (1993) Histopathology , vol.23 , Issue.2 , pp. 189-191
    • Brousset, P.1    Rochaix, P.2    Chittal, S.3
  • 33
    • 38949116321 scopus 로고    scopus 로고
    • Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas
    • March
    • Salaverria I., Beà S., Lopez-Guillermo A., et al. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas. Br J Haematol 2008, 140(March (5)):516-526.
    • (2008) Br J Haematol , vol.140 , Issue.5 , pp. 516-526
    • Salaverria, I.1    Beà, S.2    Lopez-Guillermo, A.3
  • 34
    • 33847406330 scopus 로고    scopus 로고
    • Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
    • [Epub 2006 Oct 31], March
    • Lamant L., de Reyniès A., Duplantier M.M. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood 2007, 109(March (5)):2156-2164. [Epub 2006 Oct 31].
    • (2007) Blood , vol.109 , Issue.5 , pp. 2156-2164
    • Lamant, L.1    de Reyniès, A.2    Duplantier, M.M.3
  • 35
    • 20144385625 scopus 로고    scopus 로고
    • Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas
    • May
    • Thompson M.A., Stumph J., Henrickson S.E., et al. Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 2005, 36(May (5)):494-504.
    • (2005) Hum Pathol , vol.36 , Issue.5 , pp. 494-504
    • Thompson, M.A.1    Stumph, J.2    Henrickson, S.E.3
  • 36
    • 77951906200 scopus 로고    scopus 로고
    • Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms
    • [Epub 2010 Feb 16], March
    • Piva R., Agnelli L., Pellegrino E., et al. Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms. J Clin Oncol 2010, 28(March (9)):1583-1590. [Epub 2010 Feb 16].
    • (2010) J Clin Oncol , vol.28 , Issue.9 , pp. 1583-1590
    • Piva, R.1    Agnelli, L.2    Pellegrino, E.3
  • 37
    • 47049084821 scopus 로고    scopus 로고
    • ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project
    • [Epub 2008 Apr 2], June
    • Savage K.J., Harris N.L., Vose J.M., et al. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008, 111(June (12)):5496-5504. [Epub 2008 Apr 2].
    • (2008) Blood , vol.111 , Issue.12 , pp. 5496-5504
    • Savage, K.J.1    Harris, N.L.2    Vose, J.M.3
  • 38
    • 0033570945 scopus 로고    scopus 로고
    • Lymphomas expressing ALK fusion protein(s) other than NPM-ALK
    • November
    • Falini B., Pulford K., Pucciarini A., et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999, 94(November (10)):3509-3515.
    • (1999) Blood , vol.94 , Issue.10 , pp. 3509-3515
    • Falini, B.1    Pulford, K.2    Pucciarini, A.3
  • 39
    • 20844443468 scopus 로고    scopus 로고
    • WHO-EORTC classification for cutaneous lymphomas
    • May
    • Willemze R., Jaffe E.S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005, 105(May (10)):3768-3785.
    • (2005) Blood , vol.105 , Issue.10 , pp. 3768-3785
    • Willemze, R.1    Jaffe, E.S.2    Burg, G.3
  • 40
    • 0028836518 scopus 로고
    • Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance
    • January
    • Fraga M., Brousset P., Schlaifer D. Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 1995, 103(January (1)):82-89.
    • (1995) Am J Clin Pathol , vol.103 , Issue.1 , pp. 82-89
    • Fraga, M.1    Brousset, P.2    Schlaifer, D.3
  • 41
    • 0015150080 scopus 로고
    • Report of the Committee on Hodgkin's Disease Staging Classification
    • November
    • Carbone P.P., Kaplan H.S., Musshoff K. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971, 31(November (11)):1860-1861.
    • (1971) Cancer Res , vol.31 , Issue.11 , pp. 1860-1861
    • Carbone, P.P.1    Kaplan, H.S.2    Musshoff, K.3
  • 42
    • 34848892107 scopus 로고    scopus 로고
    • FDG-PET in T-cell and NK-cell neoplasms
    • [Epub 2007 Aug 22], October
    • Kako S., Izutsu K., Ota Y., et al. FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 2007, 18(October (10)):1685-1690. [Epub 2007 Aug 22].
    • (2007) Ann Oncol , vol.18 , Issue.10 , pp. 1685-1690
    • Kako, S.1    Izutsu, K.2    Ota, Y.3
  • 43
    • 46949093658 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies
    • [Epub 2008 May 29], August
    • Khong P.L., Pang C.B., Liang R., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol 2008, 87(August (8)):613-621. [Epub 2008 May 29].
    • (2008) Ann Hematol , vol.87 , Issue.8 , pp. 613-621
    • Khong, P.L.1    Pang, C.B.2    Liang, R.3
  • 44
    • 6944238457 scopus 로고    scopus 로고
    • Towards understanding the peripheral T-cell lymphomas
    • October
    • Armitage J.O., Vose J.M., Weisenburger D.D. Towards understanding the peripheral T-cell lymphomas. Ann Oncol 2004, 15(October (10)):1447-1449.
    • (2004) Ann Oncol , vol.15 , Issue.10 , pp. 1447-1449
    • Armitage, J.O.1    Vose, J.M.2    Weisenburger, D.D.3
  • 45
    • 0033967199 scopus 로고    scopus 로고
    • Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology
    • January
    • Brugières L., Quartier P., Le Deley M.C. Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology. Ann Oncol 2000, 11(January (1)):53-58.
    • (2000) Ann Oncol , vol.11 , Issue.1 , pp. 53-58
    • Brugières, L.1    Quartier, P.2    Le Deley, M.C.3
  • 46
    • 0030822414 scopus 로고    scopus 로고
    • Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome
    • November
    • Tilly H., Gaulard P., Lepage E., et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997, 90(November (9)):3727-3734.
    • (1997) Blood , vol.90 , Issue.9 , pp. 3727-3734
    • Tilly, H.1    Gaulard, P.2    Lepage, E.3
  • 47
    • 0030447574 scopus 로고    scopus 로고
    • Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients
    • November
    • Zinzani P.L., Bendandi M., Visani G. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996, 23(November (5-6)):577-582.
    • (1996) Leuk Lymphoma , vol.23 , Issue.5-6 , pp. 577-582
    • Zinzani, P.L.1    Bendandi, M.2    Visani, G.3
  • 48
    • 12144287463 scopus 로고    scopus 로고
    • Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
    • [Epub 2003 Nov 26], April
    • Gallamini A., Stelitano C., Calvi, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004, 103(April (7)):2474-2479. [Epub 2003 Nov 26].
    • (2004) Blood , vol.103 , Issue.7 , pp. 2474-2479
    • Gallamini, A.1    Stelitano, C.2    Calvi3
  • 49
    • 0034329288 scopus 로고    scopus 로고
    • Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype
    • November
    • Suzuki R., Kagami Y., Takeuchi K., et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 2000, 96(November (9)):2993-3000.
    • (2000) Blood , vol.96 , Issue.9 , pp. 2993-3000
    • Suzuki, R.1    Kagami, Y.2    Takeuchi, K.3
  • 50
    • 78951475992 scopus 로고    scopus 로고
    • Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)
    • [abstract 322]
    • Sibon D., Fournier M., Briere J., et al. Prognostic factors and long term outcome of 138 adults with systemic anaplastic large-cell lymphoma: a retrospective study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA). Blood 2010, [abstract 322].
    • (2010) Blood
    • Sibon, D.1    Fournier, M.2    Briere, J.3
  • 51
    • 0031900563 scopus 로고    scopus 로고
    • Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients
    • April
    • Zinzani P.L., Pileri S., Bendandi M., et al. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients. J Clin Oncol 1998, 16(April (4)):1532-1537.
    • (1998) J Clin Oncol , vol.16 , Issue.4 , pp. 1532-1537
    • Zinzani, P.L.1    Pileri, S.2    Bendandi, M.3
  • 52
    • 0029094514 scopus 로고
    • Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity
    • September
    • Shiota M., Nakamura S., Ichinohasama R., et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995, 86(September (5)):1954-1960.
    • (1995) Blood , vol.86 , Issue.5 , pp. 1954-1960
    • Shiota, M.1    Nakamura, S.2    Ichinohasama, R.3
  • 53
    • 0033151520 scopus 로고    scopus 로고
    • Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
    • June
    • Gascoyne R.D., Aoun P., Wu D., et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999, 93(June (11)):3913-3921.
    • (1999) Blood , vol.93 , Issue.11 , pp. 3913-3921
    • Gascoyne, R.D.1    Aoun, P.2    Wu, D.3
  • 54
    • 78650336216 scopus 로고    scopus 로고
    • C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC
    • January
    • Moritake H., Shimonodan H., Marutsuka K., et al. C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC. Am J Hematol 2011, 86(January (1)):75-78.
    • (2011) Am J Hematol , vol.86 , Issue.1 , pp. 75-78
    • Moritake, H.1    Shimonodan, H.2    Marutsuka, K.3
  • 55
    • 0032533908 scopus 로고    scopus 로고
    • CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology
    • November
    • Brugières L., Deley M.C., Pacquement H., et al. CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 1998, 92(November (10)):3591-3598.
    • (1998) Blood , vol.92 , Issue.10 , pp. 3591-3598
    • Brugières, L.1    Deley, M.C.2    Pacquement, H.3
  • 56
    • 0032147217 scopus 로고    scopus 로고
    • Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy
    • August
    • Zinzani P.L., Martelli M., Magagnoli M. Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood 1998, 92(August (3)):790-794.
    • (1998) Blood , vol.92 , Issue.3 , pp. 790-794
    • Zinzani, P.L.1    Martelli, M.2    Magagnoli, M.3
  • 57
    • 0035086808 scopus 로고    scopus 로고
    • Long-term results with MACOP-B and radiation therapy for aggressive lymphomas
    • February
    • Krieger G., Kreysing E., Kneba M. Long-term results with MACOP-B and radiation therapy for aggressive lymphomas. Onkologie 2001, 24(February (Suppl. 1)):49-58.
    • (2001) Onkologie , vol.24 , Issue.SUPPL. 1 , pp. 49-58
    • Krieger, G.1    Kreysing, E.2    Kneba, M.3
  • 58
    • 58949083548 scopus 로고    scopus 로고
    • Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941
    • March
    • Lowe E.J., Sposto R., Perkins S.L., et al. Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941. Pediatr Blood Cancer 2009, 52(March (3)):335-339.
    • (2009) Pediatr Blood Cancer , vol.52 , Issue.3 , pp. 335-339
    • Lowe, E.J.1    Sposto, R.2    Perkins, S.L.3
  • 59
    • 0033854009 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial
    • June
    • Deconinck E., Lamy T., Foussard C., et al. Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial. Br J Haematol 2000, 109(June (4)):736-742.
    • (2000) Br J Haematol , vol.109 , Issue.4 , pp. 736-742
    • Deconinck, E.1    Lamy, T.2    Foussard, C.3
  • 60
    • 33747596427 scopus 로고    scopus 로고
    • Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation
    • [Epub 2006 Jul 27], September
    • Corradini P., Tarella C., Zallio F., et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006, 20(September (9)):1533-1538. [Epub 2006 Jul 27].
    • (2006) Leukemia , vol.20 , Issue.9 , pp. 1533-1538
    • Corradini, P.1    Tarella, C.2    Zallio, F.3
  • 61
    • 43049095718 scopus 로고    scopus 로고
    • Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
    • [Epub 2008 Feb 25], May
    • Mercadal S., Briones J., Xicoy B., et al. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 2008, 19(May (5)):958-963. [Epub 2008 Feb 25].
    • (2008) Ann Oncol , vol.19 , Issue.5 , pp. 958-963
    • Mercadal, S.1    Briones, J.2    Xicoy, B.3
  • 62
    • 34249065028 scopus 로고    scopus 로고
    • New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy
    • May
    • Rodriguez J., Gutierrez A. New treatment concepts in diffuse large B-cell lymphomas (DLBL): chemothe-rapy and biological therapy. Rev Recent Clin Trials 2007, 2(May (2)):149-162.
    • (2007) Rev Recent Clin Trials , vol.2 , Issue.2 , pp. 149-162
    • Rodriguez, J.1    Gutierrez, A.2
  • 63
    • 0025957150 scopus 로고
    • PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients)
    • January
    • Philip T., Chauvin F., Bron D., et al. PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients). Ann Oncol 1991, 2(January (Suppl. 1)):57-64.
    • (1991) Ann Oncol , vol.2 , Issue.SUPPL. 1 , pp. 57-64
    • Philip, T.1    Chauvin, F.2    Bron, D.3
  • 64
    • 0037355624 scopus 로고    scopus 로고
    • Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype
    • March
    • Song K.W., Mollee P., Keating A., Crump M. Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003, 120(March (6)):978-985.
    • (2003) Br J Haematol , vol.120 , Issue.6 , pp. 978-985
    • Song, K.W.1    Mollee, P.2    Keating, A.3    Crump, M.4
  • 65
    • 8644231731 scopus 로고    scopus 로고
    • Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant
    • November
    • Jagasia M., Morgan D., Goodman S., et al. Histology impacts the outcome of peripheral T-cell lymphomas after high dose chemotherapy and stem cell transplant. Leuk Lymphoma 2004, 45(November (11)):2261-2267.
    • (2004) Leuk Lymphoma , vol.45 , Issue.11 , pp. 2261-2267
    • Jagasia, M.1    Morgan, D.2    Goodman, S.3
  • 66
    • 44249097064 scopus 로고    scopus 로고
    • Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire
    • [Epub 2008 Apr 7], May
    • Le Gouill S., Milpied N., Buzyn A., et al. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire. J Clin Oncol 2008, 26(May (14)):2264-2271. [Epub 2008 Apr 7].
    • (2008) J Clin Oncol , vol.26 , Issue.14 , pp. 2264-2271
    • Le Gouill, S.1    Milpied, N.2    Buzyn, A.3
  • 67
    • 2942677243 scopus 로고    scopus 로고
    • Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
    • June
    • Corradini P., Dodero A., Zallio F. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004, 22(June (11)):2172-2176.
    • (2004) J Clin Oncol , vol.22 , Issue.11 , pp. 2172-2176
    • Corradini, P.1    Dodero, A.2    Zallio, F.3
  • 68
    • 33645079219 scopus 로고    scopus 로고
    • Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma
    • Bordon V., De Paepe P., Dhooge C., et al. Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma. Haematologica 2005, 90(3).
    • (2005) Haematologica , vol.90 , Issue.3
    • Bordon, V.1    De Paepe, P.2    Dhooge, C.3
  • 69
    • 67651230261 scopus 로고    scopus 로고
    • Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets
    • Rodríguez J., Gutiérrez A., Martínez-Delgado B., Perez-Manga G. Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Crit Rev Oncol Hematol 2009, 71(3):181-198.
    • (2009) Crit Rev Oncol Hematol , vol.71 , Issue.3 , pp. 181-198
    • Rodríguez, J.1    Gutiérrez, A.2    Martínez-Delgado, B.3    Perez-Manga, G.4
  • 70
    • 34447573999 scopus 로고    scopus 로고
    • Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
    • July
    • Ansell S.M., Horwitz S.M., Engert A., et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol 2007, 25(July (19)):2764-2769.
    • (2007) J Clin Oncol , vol.25 , Issue.19 , pp. 2764-2769
    • Ansell, S.M.1    Horwitz, S.M.2    Engert, A.3
  • 71
    • 0242579150 scopus 로고    scopus 로고
    • The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma
    • November
    • Borchmann P., Treml J.F., Hansen H. The human anti-CD30 antibody 5F11 shows in vitro and in vivo activity against malignant lymphoma. Blood 2003, 102(November (10)):3737-3742.
    • (2003) Blood , vol.102 , Issue.10 , pp. 3737-3742
    • Borchmann, P.1    Treml, J.F.2    Hansen, H.3
  • 72
    • 76749151760 scopus 로고    scopus 로고
    • Phase I study of an anti-CD30 Fc engineered humanized monoclonal antibody in Hodgkin lymphoma (HL) or anaplastic large cell lymphoma (ALCL) patients: Safety, pharmacokinetics (PK), immunogenicity, and efficacy
    • [abstract 8531]
    • Blum K.A., Smith M., Fung H., et al. Phase I study of an anti-CD30 Fc engineered humanized monoclonal antibody in Hodgkin lymphoma (HL) or anaplastic large cell lymphoma (ALCL) patients: Safety, pharmacokinetics (PK), immunogenicity, and efficacy. J Clin Oncol 2009, 27:15s. [abstract 8531].
    • (2009) J Clin Oncol , vol.27
    • Blum, K.A.1    Smith, M.2    Fung, H.3
  • 73
    • 0036285666 scopus 로고    scopus 로고
    • A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma
    • Schnell R., Staak O., Borchmann P., et al. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. Clin Cancer Res 2002.
    • (2002) Clin Cancer Res
    • Schnell, R.1    Staak, O.2    Borchmann, P.3
  • 74
    • 78049515807 scopus 로고    scopus 로고
    • Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas
    • November
    • Younes A., Bartlett N.L., Leonard J.P. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 2010, 363(November (19)):1812-1821.
    • (2010) N Engl J Med , vol.363 , Issue.19 , pp. 1812-1821
    • Younes, A.1    Bartlett, N.L.2    Leonard, J.P.3
  • 75
    • 78951471865 scopus 로고    scopus 로고
    • Complete remissions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma
    • [abstract 961]
    • Shustov A.R., Advani R., Brice P., et al. Complete remissions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma. Blood 2010, [abstract 961].
    • (2010) Blood
    • Shustov, A.R.1    Advani, R.2    Brice, P.3
  • 76
    • 44849126091 scopus 로고    scopus 로고
    • Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
    • May
    • McDermott U., Iafrate A.J., Gray N.S., et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res 2008, 68(May (9)):3389-3395.
    • (2008) Cancer Res , vol.68 , Issue.9 , pp. 3389-3395
    • McDermott, U.1    Iafrate, A.J.2    Gray, N.S.3
  • 77
    • 78049428879 scopus 로고    scopus 로고
    • Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor
    • October
    • Butrynski J.E., D'Adamo D.R., Hornick J.L., et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med 2010, 363(October (18)):1727-1733.
    • (2010) N Engl J Med , vol.363 , Issue.18 , pp. 1727-1733
    • Butrynski, J.E.1    D'Adamo, D.R.2    Hornick, J.L.3
  • 78
    • 44949166624 scopus 로고    scopus 로고
    • The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
    • June
    • Chiarle R., Martinengo C., Mastini C., et al. The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med 2008, 14(June (6)):676-680.
    • (2008) Nat Med , vol.14 , Issue.6 , pp. 676-680
    • Chiarle, R.1    Martinengo, C.2    Mastini, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.